Phio Pharmaceuticals Corp.
- PHIO
- NASDAQ
- Biotechnology
- Immuno-Oncology
- RNA-based Therapies
- Clinical-Stage Biotech
$0.86
Today −0.71%Quote Oct 19, 2026, 04:08 PM UTC
−14.60%over the last month
Max drawdown −15.4%From 1-month high −15.4%3 months −19.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Phio Pharmaceuticals
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
6
Founded
2003
Market value
$10.0M
Quote Oct 19
Floor
$0.84
2.9% below price
Resistance
$0.87
0.9% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PHIOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free